SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068600
Filing Date
2024-08-14
Accepted
2024-08-14 08:15:30
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210278-10q_cormedix.htm   iXBRL 10-Q 720255
2 CERTIFICATION ea021027801ex31-1_cormedix.htm EX-31.1 11028
3 CERTIFICATION ea021027801ex31-2_cormedix.htm EX-31.2 10682
4 CERTIFICATION ea021027801ex32-1_cormedix.htm EX-32.1 3820
5 CERTIFICATION ea021027801ex32-2_cormedix.htm EX-32.2 3986
  Complete submission text file 0001213900-24-068600.txt   4443143

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20240630.xsd EX-101.SCH 34857
7 XBRL CALCULATION FILE crmd-20240630_cal.xml EX-101.CAL 41484
8 XBRL DEFINITION FILE crmd-20240630_def.xml EX-101.DEF 198793
9 XBRL LABEL FILE crmd-20240630_lab.xml EX-101.LAB 357916
10 XBRL PRESENTATION FILE crmd-20240630_pre.xml EX-101.PRE 195439
58 EXTRACTED XBRL INSTANCE DOCUMENT ea0210278-10q_cormedix_htm.xml XML 521746
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 241204304
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)